"Promising Results: Innovative Treatments Shrink Aggressive Brain Tumors in Clinical Trials"

A new form of CAR-T cell therapy, called CAR-TEAM, has shown promising results in shrinking aggressive glioblastoma brain tumors in a small clinical trial at Mass General Cancer Center. Three patients experienced significant tumor shrinkage after a single infusion, with one patient's tumor remaining nearly undetectable during the follow-up period. While two patients saw tumor regrowth within six months, researchers are hopeful about the early signs of efficacy and plan to enhance the treatment's durability by combining it with chemotherapy.